Episode 2 Vision is everything: building powerful partnerships in drug and alcohol support services.
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
Partnerships in healthcare can be transformational.
They can support healthcare professionals, bring insights and value to life science companies and – most importantly of all – they can improve outcomes and experience for patients.
But it takes a lot of skill to get them right.
In Getting to the Heart of Health Partnerships, we'll explore what it takes to make them work and, crucially, what not to do.
This week, I'm delighted to be joined by David Badcock.
David is the chief executive officer of Drug Science, the leading independent scientific body providing information on drugs in the UK.
David has worked extensively in the drug and alcohol sector in organisations supporting people recovering from addiction. He and I worked together for some years in the influential London Joint Working Group on hepatitis C and substance misuse (LJWG).
I was keen to invite David onto the podcast because the constant thread running through his career has been to create unique partnerships with organisations that share a vision to help the most marginalised and vulnerable members of our communities.
Today, we'll hear from David about the challenges and lessons of setting up and nurturing partnerships that drive change for some of the people who most need it.
Email claire@dovetailstrategies.com or connect on LinkedIn to send questions and comments about anything you've heard in this episode. I'd love to hear from you.
Thank you for listening, and see you next time!
Follow David on Twitter https://twitter.com/badcockdavid and LinkedIn http://www.linkedin.com/in/david-badcock
Follow Drug Science on Twitter https://twitter.com/Drug_Science
Follow Claire on LinkedIn https://www.linkedin.com/in/claire-munro-0b59b05
Find out more about Dovetail dovetailstrategies.com